| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fe23d6754a4999c6cbe01c3dd82b445 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 |
| filingDate |
2004-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c463a2b7112660a197f1624cfecd7e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98286a9bcd212a392e34d66314b55467
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a19853cf2a674423a2be25f357bf21e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4215d0223ab633f39de39f3ee6a43072 |
| publicationDate |
2004-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004064726-A3 |
| titleOfInvention |
Bioavailable fenofibrate compositions, methods for treating hyperlipidemia and hypercholesterolemia and processes for the preparation of such compositions |
| abstract |
Pharmaceutical compositions for treating hyperlipidemia or hypercholesterolemia in mammals are described which comprise: (a) fenofibrate 5 to 35 wt.-%; (b) a cyclodextrin 4 to 30 wt.-%; (c) an alkali metal or alkaline earth metal docusate and/or alkali metal or alkaline earth metal lauryl sulfate 0.1 to 10 wt.-%; and (d) a water-insoluble, wettable inorganic carrier capable of forming a dispersion of the fenofibrate 5 to 30 wt.-% and a pharmaceutically acceptable inert carrier or diluent. A therapeutically effective amount of the compositions are orally administered to mammals to treat hyperlipidemia or hypercholesterolemia. |
| priorityDate |
2003-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |